Tailoring imaging probes for defining glioma invasive margins: Tracing the molecular footprints of cancer cells
Biomaterials · 2026-04 · 327 · 123779
DOI: 10.1016/j.biomaterials.2025.123779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials, 2026-04. Verfasst von Qian He und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Margins of Excision. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Key Research and Development Program of China Stem Cell and Translational Research, Shanghai Rising-Star Program.
Abstract (Originalsprache)
Maximal safe surgical resection remains the cornerstone of glioma treatment, yet the infiltrative nature of this most common malignant brain tumor poses major challenges in accurately delineating tumor margins while preserving adjacent functional tissues. Addressing this limitation requires the identification of reliable invasion biomarkers and the development of highly specific materials to enable complete resection of diffuse glioma. This review explores the infiltrative growth patterns of glioma and classifies margin-associated biomarkers into three major categorizes: molecular, cellular and structural abnormities. Particular emphasis is placed on molecular and functional biomarkers, which often manifest earlier and more faithfully reflect cancer cell distribution than structural markers. We also highlight recent advancements in engineering materials and probes capable of detecting these abnormalities beyond the reach of conventional diagnostic tools, thereby enhancing intraoperative precision. Finally, we outline future perspectives for refining biomarker discovery and probe design to facilitate maximal safe resection. By advancing next-generation technologies for delineating diffuse glioma margins, these efforts hold promise for improving surgical outcomes and patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai, 201203, China.
- Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, 1649-004, Portugal. Electronic address: lgraca@medicina.ulisboa.pt.
- Shengjing Hospital Affiliated to China Medical University, 36 Sanhao Street, Heping District, Shenyang City, Liaoning Province, 110004, China. Electronic address: sunhz@sj-hospital.org.
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai, 201203, China; MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of I…
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China Stem Cell and Translational Research
- Shanghai Rising-Star Program
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
Zitieren
APA
He, Q., Yang, M., Wang, P., Graca, L., Sun, H., & Li, C. (2026). Tailoring imaging probes for defining glioma invasive margins: Tracing the molecular footprints of cancer cells. Biomaterials, 327, 123779. https://doi.org/10.1016/j.biomaterials.2025.123779
Vancouver
He Q, Yang M, Wang P, Graca L, Sun H, Li C. Tailoring imaging probes for defining glioma invasive margins: Tracing the molecular footprints of cancer cells. Biomaterials. 2026;327:123779. doi:10.1016/j.biomaterials.2025.123779
BibTeX
@article{He2026,
author = {He, Qian and Yang, Minghao and Wang, Pengwei and Graca, Luis and Sun, Hongzan and Li, Cong},
title = {Tailoring imaging probes for defining glioma invasive margins: Tracing the molecular footprints of cancer cells},
journal = {Biomaterials},
year = {2026},
volume = {327},
pages = {123779},
doi = {10.1016/j.biomaterials.2025.123779}
}
EUVIMED